MoneyWorks4Me

Shamrock Indl. Co - Quaterly Results

10 Feb 2024 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended December 2023. The figure stood at Rs. 0.00 millions during the year-ago period.The Net Loss for the quarter ended December 2023 is Rs. -0.50 millions as compared to Net Loss of Rs. -0.38 millions of corresponding quarter ended December 2022 Operating profit Margin for the quarter ended December 2023 further decreased to -0.50% as compared to -0.37% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 1.12 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.97 0.00
PBIDT -0.50 -0.37 35.14 -0.22 -1.06 -79.25 -1.28 -2.07 -38.16
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.50 -0.37 35.14 -0.22 -1.06 -79.25 -1.28 -2.07 -38.16
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.50 -0.37 35.14 -0.22 -1.06 -79.25 -1.28 -2.07 -38.16
TAX 0.00 0.01 0.00 0.00 0.01 0.00 0.01 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.50 -0.38 31.58 -0.22 -1.07 -79.44 -1.29 -2.07 -37.68
Equity 54.28 54.28 0.00 54.28 54.28 0.00 54.28 54.28 0.00
PBIDTM(%) 0.00 0.00 0.00 -19.64 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..